Assays Featured Articles
-
GE Healthcare Launches FF High Performance Nitrocellulose Membranes Optimized For Diagnostic Assay Reproducibility
8/1/2012
GE Healthcare Life Sciences’ new Whatman FF High Performance (HP) membrane provides the industry with a new diagnostic membrane to enable fast, razor-sharp line separation and highly reproducible results for the detection of target molecules in liquids such as water, urine, blood and saliva.
-
Stago Launches Products For Measurement Of Rivaroxaban
7/16/2012
The STA – Rivaroxaban Calibrator and Controls are highly specific, automation-ready products for determining the rivaroxaban concentration in plasma when used in conjunction with the STA - Liquid Anti-Xa assay.
-
BINDER ANTI.PLENUM CO2 Incubators Reduce Threat Of Contamination
6/11/2012
BINDER CO2 incubators with ANTI.PLENUM design reduce the probability of contamination in the unit interior by a factor of three. The deep-drawn inner chamber with integrated shelf fixtures and large, rounded corners, the core of the design, provides such additional benefits as ease of care and reduced overall expenses.
-
InnoCal® Calibration and Repair Adds Services
5/31/2012
InnoCal®, a division of Cole-Parmer, has added calibration services for the metrology lab that now calibrates mixers, stirrers, hot plates, incubators, ovens, refrigerators, freezers, pipettes, and viscometers.
-
Thermo Fisher Scientific Introduces Next-Generation Benchtop LC-MS System At ASMS 2012
5/21/2012
Thermo Fisher Scientific Inc., the world leader in serving science, recently announced the Thermo Scientific Exactive Plus system, the company’s latest benchtop liquid chromatography-mass spectrometry (LC-MS) system for high-throughput screening, identification and quantification of compounds in complex matrices.
-
Evotec Becomes The First Contract Research Facility In Europe To Offer Agilent's RapidFire/MS Screening For Pharmaceutical Drug Discovery
5/16/2012
Evotec AG is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.
-
IntelligentMDx Announces CE-Marking Of A New High-Throughput Test For Group B Streptococcus Intended To Improve Women’s Health And Prenatal Care
5/15/2012
IntelligentMDx (IMDx) announced recently that it has obtained CE-marking for a new automated, high-throughput, qualitative in vitro diagnostic test designed for the rapid detection of Group B Streptococcus (GBS) for use in screening pregnant women and those in labor who may be infected with the pathogen.
-
Ultrasound Idea: Prototype NIST/CU Bioreactor Evaluates Engineered Tissue While Creating It
5/2/2012
Researchers at the National Institute of Standards and Technology (NIST) have developed a prototype bioreactor—a device for culturing cells to create engineered tissues—that both stimulates and evaluates tissue as it grows, mimicking natural processes while eliminating the need to stop periodically to cut up samples for analysis.
-
QIAGEN Receives FDA Clearances For Rotor-Gene Q MDx Instrument And Compatible Influenza A/B Assay
4/18/2012
QIAGEN N.V., recently announced that the U.S. Food and Drug Administration (FDA) has granted two 510(k) clearances for its real-time PCR (polymerase chain reaction) instrument Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG RT-PCR Kit, for in vitro diagnostic use (IVD).
-
Screening For Optimal Algal Cell Growth And Neutral Lipid Production Conditions In Microplates
2/23/2012
The increase in the price of fossil fuel based products, such as gasoline and diesel fuel and the ever present reality of global climate change has brought an increased interest in the use of renewable sources of energy products.